Given the strong market demand for chemotherapy treatments and the projected growth in the closed system transfer devices market, I invested in WST to...
Read More
Given the strong market demand for chemotherapy treatments and the projected growth in the closed system transfer devices market, I invested in WST to capitalize on its potential revenue boost and robust performance in the Proprietary Products business.